Key Highlights

• Challenger reported total life sales up 12 per cent to A$9.6 billion.

• Cost growth was 1 per cent and the cost-to-income ratio was 32.1 per cent, at the bottom of the target range.

• For FY2027, the company guided core Basic Earnings Per Share of 45 to 49 cents, with a midpoint of 47 cents, which is a 6 per cent increase on FY2026 core earnings per share of 44.2 cents, according to the financial news report.

• Statutory profit can swing sharply, as the movement from A$192 million to A$506 million shows.

How does a retirement income provider grow its Annuity book and still return more Capital to shareholders? Challenger's (ASX:CGF) FY2026 result, announced on 18 August 2026 for the year to 30 June 2026, offers a detailed example. Total life sales rose to A$9.6 billion, normalised net profit after tax was A$468 million, the on-market buy-back was increased to A$450 million, and the company launched a A$6 billion annuity-backed notes programme in July 2026. The currency is presumed to be Australian dollars, since the summaries use the "$" sign without naming it.

The central development: sales growth and a larger buy-back

Challenger reported total life sales up 12 per cent to A$9.6 billion. Annuity sales rose 19 per cent to A$6.2 billion, and offshore Reinsurance annuity sales reached a record A$1.2 billion, up 25 per cent. The annuity book grew by 10.7 per cent.

Normalised Return on Equity was 11.6 per cent, which the company described as above target.

The full-year ordinary Dividend was 31.5 cents per share, up 7 per cent, with a 1.5 cent special dividend. The on-market buy-back was lifted to A$450 million, comprising a previously announced A$150 million and a further A$300 million, subject to market conditions and regulatory approval.

Business model and Revenue drivers

Challenger writes annuities, which are products that pay a regular income, and invests the premiums in a portfolio, earning a Margin over what it pays to customers. It also owns a funds management business. Profit therefore depends on the size of the life book, the margin earned on it, Investment performance, and costs. New Business must be backed by capital, which is why capital ratios matter.

Cost growth was 1 per cent and the cost-to-income ratio was 32.1 per cent, at the bottom of the target range. Total investment Assets under management were A$26.6 billion, up 4 per cent.

Capital strength

Challenger's life company reported a prescribed capital amount (PCA) ratio of 1.38 times, and 1.50 times on a pro forma basis under new capital standards. The PCA ratio is a regulatory Solvency measure and is not the same as the common equity tier 1 ratio used by banks.

Readers should check the programme documentation.

Guidance and targets

For FY2027, the company guided core basic earnings per share of 45 to 49 cents, with a midpoint of 47 cents, which is a 6 per cent increase on FY2026 core earnings per share of 44.2 cents, according to the financial news report. Core earnings per share is a different measure from normalised earnings per share of 68.1 cents, and the two should not be compared directly.

Medium-term targets are operating EPS growth of 8 to 10 per cent a year compounded and a dividend Payout Ratio of 65 to 75 per cent. The Fidante and Channel Capital Merger is due for completion in the late first half of FY2027. Mergers of this kind can bring integration costs and management distraction alongside any scale benefits.

Sector and competitive position

Challenger operates in Australia's retirement income market, where Demand is supported by an ageing population and compulsory superannuation.

Risks and developments to monitor

Risks include investment market Volatility and Credit losses affecting the investment portfolio, Interest Rate changes, competition on annuity pricing, regulatory changes to capital standards or superannuation, and execution of growth through reinsurance. Statutory profit can swing sharply, as the movement from A$192 million to A$506 million shows.

Items to watch include progress on the buy-back and its regulatory approvals, the first-half FY2027 result for core EPS progress against the 45 to 49 cent guide, annuity sales in quarterly updates, the capital ratio under the new standards, and completion of the Fidante and Channel Capital merger.